Erica Erlank to Plasmodium falciparum
This is a "connection" page, showing publications Erica Erlank has written about Plasmodium falciparum.
Connection Strength
0,535
-
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors. J Vis Exp. 2022 May 12; (183).
Score: 0,188
-
Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite Plasmodium falciparum and Optimization Efforts. J Med Chem. 2021 02 25; 64(4):2291-2309.
Score: 0,172
-
The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages. Sci Transl Med. 2022 10 19; 14(667):eabo7219.
Score: 0,048
-
Benzimidazole Derivatives Are Potent against Multiple Life Cycle Stages of Plasmodium falciparum Malaria Parasites. ACS Infect Dis. 2021 07 09; 7(7):1945-1955.
Score: 0,043
-
Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box. Nat Commun. 2021 01 11; 12(1):269.
Score: 0,043
-
Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial. Lancet. 2020 04 25; 395(10233):1361-1373.
Score: 0,041